Pavaki Capital Management LLC
CIK 0002143027 · PUEBLO, CO · Quarter end: 2025-12-31 · Filed on: 2026-08-07 · Open the SEC source ↗
The most recent 13F EDGAR holds under this CIK is 2025 Q4, filed 2026-08-07. Nothing has been filed since — the fund stopped filing, or it files under a different entity now. The positions below are a snapshot of that date, not a current portfolio.
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$142.0M
2025 Q4
Positions
87
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
59.8%
Est. Net Flow (Q)
—
2025 Q4
Top Holdings
MIST
MILESTONE PHARMACEUTICALS IN
12.1%
REGN
REGENERON PHARMACEUTICALS
10.5%
SPRY
SILVERBACK THERAPEUTICS INC
9.6%
B
BARRICK MNG CORP
5.9%
DIS
DISNEY WALT CO
4.9%
ARQT
ARCUTIS BIOTHERAPEUTICS INC
4.1%
BTG
B2GOLD CORP
3.7%
OGN
ORGANON & CO COMMON
3.7%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.